A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins

New England Journal of Medicine

Volumn 357, Issue 5, 2007, Pages 454-461

  Rouse, Dwight J ^a,r   Caritis, Steve N ^b   Peaceman, Alan M ^c   Sciscione, Anthony ^d   Thom, Elizabeth A ^e   Spong, Catherine Y ^f   Varner, Michael ^g   Malone, Fergal ^h   Iams, Jay D ⁱ   Mercer, Brian M ^j   Thorp, John ^k   Sorokin, Yoram ^l   Carpenter, Marshall ^m   Lo, Julie ⁿ   Ramin, Susan ^o   Harper, Margaret ^p   Anderson, Garland ^q  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d DREXEL UNIVERSITY   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g UNIVERSITY OF UTAH   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j CASE WESTERN RESERVE UNIVERSITY   (United States)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

^l WAYNE STATE UNIVERSITY   (United States)

^m BROWN UNIVERSITY   (United States)

ⁿ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^o UNIVERSITY OF TEXAS   (United States)

^p WAKE FOREST UNIVERSITY   (United States)

^q UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; PLACEBO;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; FETUS; FETUS DEATH; FOLLOW UP; GESTATIONAL AGE; HEART PALPITATION; HUMAN; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NEWBORN; NEWBORN PERIOD; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREMATURITY; PRESYNCOPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TWIN PREGNANCY; TWINS; UNSPECIFIED SIDE EFFECT; URTICARIA;

EID: 34547647628     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa070641     Document Type: Article

References (14)

1. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2004. National vital statistics reports. Vol. 55. No. 1. Hyattsville, MD: National Center for Health Statistics, 2006.
2. Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85. [Erratum, N Engl J Med 2003;349:1299.]
3. Petrini JR, Callaghan WM, Klebanoff M, et al. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol 2005;105:267-72.
4. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2003 period linked birth/infant death data set. National vital statistics reports. Vol. 54. No. 16. Hyattsville, MD: National Center for Health Statistics, 2006.
5. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-40.
6. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials 1988;9:345-64. [Erratum, Control Clin Trials 1989;10:following 126.]
7. Cnaan A, Ryan L. Survival analysis in natural history studies of disease. Stat Med 1989;8:1255-68.
8. Goldenberg RL, Iams JD, Miodovnik M, et al. The Preterm Prediction Study: risk factors in twin gestations. Am J Obstet Gynecol 1996;175:1047-53.
9. Caritis S, Sibai B, Hauth J, et al. Lowdose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998;338:701-5.
10. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
11. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2006;194:1234-42.
12. Hartikainen-Sorri AL, Kauppila A, Tuimala R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980;56:692-5.
13. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462-9.
14. Pritchard JA. Changes in the blood volume during pregnancy. Anesthesiology 1965;26:393-9.